Danaher Corp
DHR
Company Profile
Business description
In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Contact
2200 Pennsylvania Avenue, NW
Suite 800W
WashingtonDC20037-1701
USAT: +1 202 828-0850
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
60,000
Stocks News & Analysis
stocks
OpenAI is going public as the worst value among its peers
Investors are paying a steep price relative to the underlying business quality, PitchBook research says.
stocks
Wide moat healthcare leader remains undervalued
ASX healthcare giant expected to see uptick in demand from emerging markets.
stocks
This US AI winner has been unstoppable. Is it time to sell?
Astonishing results have driven this AI stock into significantly overvalued territory.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,855.90 | 79.60 | -0.89% |
| CAC 40 | 8,242.55 | 1.74 | -0.02% |
| DAX 40 | 24,841.28 | 103.67 | -0.42% |
| Dow JONES (US) | 51,501.57 | 60.36 | -0.12% |
| FTSE 100 | 10,388.53 | 28.21 | 0.27% |
| HKSE | 24,961.95 | 291.45 | -1.15% |
| NASDAQ | 26,494.60 | 336.36 | -1.25% |
| Nikkei 225 | 66,588.12 | 882.57 | -1.31% |
| NZX 50 Index | 13,161.97 | 60.36 | 0.46% |
| S&P 500 | 7,529.78 | 54.53 | -0.72% |
| S&P/ASX 200 | 8,625.10 | 80.00 | -0.92% |
| SSE Composite Index | 4,027.74 | 30.04 | -0.74% |